<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Human Prescription Drug and Biological Products-Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers-“Dose Banding”; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Human Prescription Drug and Biological Products-Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers-“Dose Banding”; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-07-21 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--`Dose Banding'." The guidance is intended to assist applicants in incorporating dose banding information into the drug labeling provided in a new drug application (NDA) submitted under the Federal Food, Drug, and Cosmetic Act (FD&C Act), a bi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-15523</p>
    <p><strong>Publication Date:</strong> 2022-07-21</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/07/21/2022-15523/human-prescription-drug-and-biological-products-labeling-for-dosing-based-on-weight-or-body-surface">https://www.federalregister.gov/documents/2022/07/21/2022-15523/human-prescription-drug-and-biological-products-labeling-for-dosing-based-on-weight-or-body-surface</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-15523</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
